BioRestorative Therapies Inc (BRTX) earnings · rev $359.7K
These earnings events as JSON? API free 100/dayBioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
This BRTX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported BRTX revenue for 2025-12-31 was $359.7K. Net income was -$14.2M. Revenue was down 10.3% from 2024-12-31 to 2025-12-31. BRTX currently screens at market cap $10.2M.
When the next BRTX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 10.3% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full BRTX research stays on the stock page; the tape stays on the quote page.
BRTX earnings FAQ
What are BRTX's latest revenue and net income?
Latest cached BioRestorative Therapies Inc (BRTX) revenue for Dec 31, 2025 was $359.7K. Net income was -$14.2M. Statements: https://lician.com/financials/brtx
What is BRTX's latest diluted EPS?
Latest cached BioRestorative Therapies Inc (BRTX) diluted EPS for Dec 31, 2025 was -$1.58.
What period does the latest BRTX earnings print cover?
The latest cached BioRestorative Therapies Inc (BRTX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did BRTX revenue change from the prior cached period?
Cached BioRestorative Therapies Inc (BRTX) revenue was down 10.3% from $401.0K (Dec 31, 2024) to $359.7K (Dec 31, 2025). Statements: https://lician.com/financials/brtx
Where are BRTX earnings listed?
Cached earnings facts for BioRestorative Therapies Inc (BRTX) are listed at https://lician.com/earnings/brtx. Statements: https://lician.com/financials/brtx
Not investment advice.